Omega Therapeutics Stock Analysis

Omega Stock Analysis Notes

About 90.0% of the company shares are owned by institutional investors. The book value of Omega Therapeutics was now reported as 1.05. The company recorded a loss per share of 1.32. Omega Therapeutics had not issued any dividends in recent years. Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Omega Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 79 people. To find out more about Omega Therapeutics contact Mahesh Karande at 617 949 4360 or learn more at https://omegatherapeutics.com.

Omega Therapeutics Investment Alerts

Omega Therapeutics Upcoming and Recent Events

Omega Largest EPS Surprises

View All Earnings Estimates

Omega Stock Institutional Investors

Note, although Omega Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Omega Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 43.52 M.

Omega Profitablity

Management Efficiency

Omega Therapeutics has return on total asset (ROA) of (0.2537) % which means that it has lost $0.2537 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2915) %, meaning that it created substantial loss on money invested by shareholders. Omega Therapeutics' management efficiency ratios could be used to measure how well Omega Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of November 25, 2024, Return On Tangible Assets is expected to decline to -0.5. In addition to that, Return On Capital Employed is expected to decline to -0.59. At present, Omega Therapeutics' Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 120.2 M, whereas Total Assets are forecasted to decline to about 135.9 M.

Technical Drivers

As of the 25th of November, Omega Therapeutics holds the Coefficient Of Variation of (807.22), variance of 41.06, and Risk Adjusted Performance of (0.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Omega Therapeutics, as well as the relationship between them.

Omega Therapeutics Price Movement Analysis

Omega Therapeutics Insider Trading Activities

Omega Therapeutics Outstanding Bonds

Omega Therapeutics Predictive Daily Indicators

Omega Therapeutics Forecast Models

Omega Therapeutics' time-series forecasting models are one of many Omega Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Omega Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Omega Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Omega shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Omega Therapeutics. By using and applying Omega Stock analysis, traders can create a robust methodology for identifying Omega entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Omega analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Omega analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Omega Therapeutics stock analysis indicators help investors evaluate how Omega Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Omega Therapeutics shares will generate the highest return on investment. By understating and applying Omega Therapeutics stock analysis, traders can identify Omega Therapeutics position entry and exit signals to maximize returns.

When running Omega Therapeutics' price analysis, check to measure Omega Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Therapeutics is operating at the current time. Most of Omega Therapeutics' value examination focuses on studying past and present price action to predict the probability of Omega Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Therapeutics' price. Additionally, you may evaluate how the addition of Omega Therapeutics to your portfolios can decrease your overall portfolio volatility.